NV
enVVeno Medical Corporation
NVNO · NASDAQ
$9.38 -6.48% (-$0.65)
1M -11.10%
Market Cap $154.8K
P/E Ratio -
Div. Yield -
ROE 62.28%
Bulios Fair Price
$10.88
16.0% upside
Current Price
$9.38
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NVNO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.01x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 11.19%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 79.12%
ROE 62.28%
ROA 69.39%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 11.70x
Int. coverage N/A
Stability
49 /100
Moderate Beta 1.07x
EPS volatility 44.21%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NVNO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert A. Berman
Employees
33
Headquarters
Irvine
Upcoming events
30 OCT
Earnings
Upcoming earnings report